FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia (Q33425207)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia |
scientific article |
Statements
1 reference
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia (English)
1 reference
R Angelo de Claro
1 reference
Karen M McGinn
1 reference
Nicole Verdun
1 reference
Shwu-Luan Lee
1 reference
Haw-Jyh Chiu
1 reference
Haleh Saber
1 reference
Margaret E Brower
1 reference
C J George Chang
1 reference
Elimika Pfuma
1 reference
Bahru Habtemariam
1 reference
Julie Bullock
1 reference
Yun Wang
1 reference
Lei Nie
1 reference
Xiao-Hong Chen
1 reference
Donghao Robert Lu
1 reference
Ali Al-Hakim
1 reference
Robert C Kane
1 reference
Edvardas Kaminskas
1 reference
Robert Justice
1 reference
Ann T Farrell
1 reference
Richard Pazdur
1 reference
1 reference
Identifiers
1 reference